Deutsche Bank downgraded Amedisys to Hold from Buy with a $101 price target. The analyst believes Amedisys’ recent divestiture of certain home health assets signals progress towards the Optum takeover closure this year.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMED:
- Amedisys Releases Q2 Supplemental Financial Slides
- Amedisys reports Q2 adjusted EPS $1.32, consensus $1.18
- Birkenstock upgraded, Charter initiated: Wall Street’s top analyst calls
- William Blair downgrades Amedisys on tighter takeover spread
- Amedisys, UnitedHealth to divest home health care centers to VitalCaring
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue